POSTER BOARD NUMBERS

LUPUS 2017 & ACA 2017 | Melbourne, Australia

Monday, 27 March

* Boards PS01-PS04 are located in the foyer outside Room 203-204. These posters should be on display

throughout the Congress.

Last name First name Poster title Board number

Agarwal Manjari LUPUS NEPHRITIS IN CHILDREN: A 7 YEAR SINGLE CENTRE EXPERIENCE FROM INDIA

063

Anggara Mohamad Yanuar AUTOIMMUNE HEMOLYTIC ANEMIA EVOLVING TO SYSTEMIC LUPUS ERYTHREMATOSUS

064

Aravinthan Adithan ENHANCED IMMUNE CELL ACTIVITY BY KOREAN RED GINSENG IN PORCINE

001

Aravinthan Adithan GASTRIC CANCER CELL MICRO ENVIRONMENT MODULATES THE NK CELL EFFICACY IN RAT SPLENOCYTES

002

Azhar Ahmad CARDIOVASCULAR COMPLICATIONS IN PEDIATRIC-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS IN SAUDI ARABIAN PATIENTS

065

Barrera-Vargas Ana IS SPLENECTOMY A SAFE AND EFFECTIVE THERAPEUTIC OPTION IN SYSTEMIC LUPUS ERYTHEMATOSUS? A SINGLE-CENTER STUDY

025

Bengtsson Anders A LOW PLASMA CONCENTRATIONS OF APOLIPOPROTEIN M CORRELATE TO DISEASE ACTIVITY AND ENDOTHELIAL DYSFUNCTION IN SLE

078

Campos Lucia OUTCOMES OF 847 CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOUSUS PATIENTS IN THREE AGE GROUPS

066

Campos Lucia PANNICULITIS IN CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS: A MULTICENTRIC COHORT STUDY

067

Carvalho Jozelio SUBCLINICAL MYOCARDIAL DYSFUNCTION BY TISSUE DOPPLER ECHOCARDIOGRAPHY IN PRIMARY ANTIPHOSPHOLIPID SYNDROME: PRELIMINARY RESULTS

014

Cefle Ayse SINGLE CENTER EXPERIENCE WITH 150 SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

123

Cheung Kwok Fan ANNEXIN II-BINDING IMMUNOGLOBULIN G LEVEL CORRELATES WITH CLINICAL AND RENAL HISTOLOGICAL DISEASE ACTIVITY IN LUPUS NEPHRITIS

124

Cho Chul-Soo INCREASED URINARY HEPARANASE LEVELS ARE ASSOCIATED WITH ACTIVE LUPUS NEPHRITIS

125

Choi Yun Jung INDUCTION OF DIFFERENTIATION OF REGULATORY T CELLS COUPLED TO ENDOPLASMIC RETICULUM STRESS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

003

Choi Chan-Bum OUTCOMES OF MULTI-TARGET THERAPY USING MYCOPHENOLATE MOFETIL AND TACROLIMUS FOR REFRACTORY LUPUS NEPHRITIS

026

Choi Yun Jung SUBCLINICAL DETERIORATION OF LEFT VENTRICULAR DIASTOLIC FUNCTION IN SYSTEMIC LUPUS ERYTHEMATOSUS

126

Choy Hoikei EDA+ FIBRONECTIN IN TUBULO-INTERSTITIAL INJURY IN LUPUS NEPHRITIS

127

Cunanan Iricel ANTIPHOSPHOLIPID ANTIBODY SYNDROME PRESENTING AS SPONTANEOUS HEPATIC RUPTURE

015

Deng Guo-min ETHANOL PREVENTS DAMAGE OF SKIN, KIDNEY AND JOINT IN LUPUS-PRONE MICE BY REGULATING LIPID RAFTS

027

Deng Guo-min JOINT DEPOSITED IGG INDUCES ARTHRITIS BUT INHIBITS OSTEOCLASTOGENESIS IN SLE THROUGH SYK

128

Deng Guo-min ESTROGEN PROMOTES SLE SERUM IgG-induced SKIN INFLAMMATION VIA THE ESTROGEN MEMBRANE RECEPTOR GPER1

129

Deng Guo-min THE MAJOR ROLES OF MONOCYTES AND THEIR PRODUCT TUMOR NECROSIS FACTOR ALPHA IN THE INDUCTION OF SKIN INFLAMMATION TRIGGERED BY INTRADERMAL LUPUS IgG

130

Deng Guo-min THE ROLE OF IL-1 IN SKIN INFLAMMATION INDUCED BY LUPUS SERUM IgG

131

Dubisnky Diana HPV-RELATED PREMALIGNANT AND MALIGNANT LESIONS IN THE LOWER GENITAL AND ANAL TRACTS OF WOMEN WITH SLE

079

Edar Mary Flor Joy CONTRIBUTORS TO DISEASE FLARES AMONG FILIPINO PATIENTS WITH SLE

084

Eldar-Lissai Adi DISEASE BURDEN AND HEALTHCARE RESOURCE UTILIZATION AMONG CUTANEOUS LUPUS ERYTHEMATOSUS PATIENTS WITH DEPRESSION AND/OR ANXIETY; QUANTIFYING THE UNMET NEED

082

Erceg Mary A PATIENT’S FOUR DECADE JOURNEY TO WELLNESS : A MODEL OF CARE FOR LIVING WELL WITH LUPUS

PS-01*

Falanag Marina THE ITALIAN SLE SURVEY BY WEB: INVESTIGATING PATIENTS’ UNMET NEEDS WITH ONLINE SURVEY TOOLS

PS-02*

Fang Xiang HEPATIC DEPOSITED IgG MEDIATED LIVER DAMAGE THROUGH KUPFFER/NATURAL KILLER CELLS AND THEIR PRODUCTS

132

Fernandes das Neves

Marisa ANTIBODIES TOWARDS ATP-BINDING CASSETTE TRANSPORTER ABCA1: A NEW MECHANISM FOR ATHEROSCLEROSIS IN SLE?

083

Fikry Achmad RHUPUS SYNDROME : A CASE REPORT AND LITERATURE REVIEW 133

Furie Richard BIIB059, A MONOCLONAL ANTIBODY TARGETING BDCA2, DEMONSTRATES EVIDENCE OF PROOF OF BIOLOGICAL ACTIVITY IN SUBJECTS WITH CUTANEOUS LUPUS

028

G Arvind STUDY OF CLINICAL UTILITY OF ANTIBODIES TO PHOSPHATIDYLSERINE/ PROTHROMBIN COMPLEX IN INDIAN PATIENTS

016

G Dharmanand Balebail PROSPECTIVE SINGLE CENTRE STUDY OF EFFECTIVENESS OF UPFRONT RITUXIMAB AND MYCOPHENOLATE WITH MINIMUM STEROID IN SLE

029

Gladman Dafna ACCRUAL OF DISEASE COMORBIDITIES OVER 8 YEARS IN A MULTICENTRE INCEPTION SLE COHORT

100

Gladman Dafna ASSOCIATION BETWEEN CHRONIC ANTIMALARIAL THERAPY AND ELEVATED MYOCARDIAL BIOMARKERS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND NO PRIOR HEART DISEASE: A PRELIMINARY REPORT

101

Gladman Dafna EFFECT OF COMPLETE OR PARTIAL PROTEINURIA RECOVERY COMPARED TO NO RECOVERY AT 2 YEARS AFTER THE DIAGNOSIS OF LUPUS NEPHRITIS ON LONG TERM OUTCOMES

138

Gómez-Puerta Jose A SAFETY OF BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN CLINICAL PRACTICE SETTING

030

Gunawan Hendra NEUTROPHIL-TO-LYMPHOCYTE RATIO AND SYSTEMIC LUPUS ERYTHEMATOSUS: A NEW PARAMETER FOR DISEASE ACTIVITY ASSESSMENT?

085

Gunawan Hendra DYSLIPIDEMIA AND DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOUS: AN INDEPENDENT RISK FACTOR

086

Guo Qiang PULMONARY DISORDERS IN LUPUS PATIENT WITH NEPHRITIS 087

Gupta Neetu THE MEMBRANE-CYTOSKELETON LINKER EZRIN AND Src FAMILY KINASE LYN COLLABORATE TO MAINTAIN OPTIMAL B CELL ACTIVATION AND PREVENT THE DEVELOPMENT OF AUTOIMMUNITY

004

Gupta Aman SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID ANTIBODIES IN A CHILD WITH NOONAN SYNDROME

068

Hall Susan Audrey SYMPTOM IMPACT AND UNMET NEED IN SYSTEMIC/CUTANEOUS LUPUS ERYTHEMATOSUS: RESULTS FROM A PATIENT-CENTERED STUDY SET IN A SOCIAL MEDIA COMMUNITY

088

Hamijoyo Laniyati ASSOCIATION BETWEEN HYPERTENSION AND PROTEINURIA IN SYSTEMIC LUPUS ERYTHEMATOSUS

089

Hanly John SJOGREN’S SYNDROME AND LOCALIZED NODULAR CUTANEOUS AMYLOIDOSIS: NEW INSIGHTS INTO THE LINK BETWEEN THE TWO

090

Hellmi Rakhma yanti CORRELATION BETWEEN PLASMA LEVELS OF TNF-α AND CAROTID ARTERY INTIMA MEDIA THICKNESS IN SLE

091

Hitchon Carol ACTIVE ARTHRITIS IS ASSOCIATED WITH 14-3-3eta TITRE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

134

Inanc Nevsun EARLY RESULTS OF PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AND SYSTEMIC LUPUS ERYTHEMATOSUS FOLLOWING PULMONARY ENDARTERECTOMY

092

Ishizaka Sally SELECTIVE AND ORALLY AVAILABLE SMALL MOLECULE INHIBITORS OF TLR7 AND 8 FOR THE TREATMENT OF LUPUS

031

Islam Md. Nazrul CLINICAL EVALUATION OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS FOR SKIN LESIONS-REPORT FROM A DEVELOPING COUNTRY

093

Itomi Yasuo IXAZOMIB, AN ORAL PROTEASOME INHIBITOR, REDUCES ANTIBODY PRODUCTION BY DEPLETING PLASMA CELLS IN A T CELL DEPENDENT ANTIGEN RESPONSE MODEL

005

Itomi Yasuo IXAZOMIB, AN ORAL PROTEASOME INHIBITOR, DEPLETES PLASMA CELLS REDUCING AUTOANTIBODIES AND pDCs in PRE-CLINICAL MODEL OF SYSTEMIC LUPUS ERYTHEMATOSUS

032

Jarjour Wael TLR7 AND TLR8 TARGETED Micro-RNAs INHIBIT SIGNALING AND SUPPRESS INFLAMMATION IN A NOVEL HUMAN-MOUSE CHIMERIC MODEL OF SYSTEMIC LUPUS ERYTHEMATOSUS

033

Jindal Ankur RITUXIMAB IN THE MANAGEMENT OF ANTIPHOSPHOLIPID ANTIBODIES ASSOCIATED CHOREA IN A CHILD WITH LUPUS

017

Jindal Ankur AN UNUSUAL CASE OF PEDIATRIC LUPUS WITH ISOLATED RETINAL INVOLVEMENT

069

Jindal Ankur SKIN PEELING AND IRRITABILITY IN A YOUNG BOY WITH SYSTEMIC LUPUS ERYTHEMATOSUS- IS THERE AN OVERLAP WITH KAWASAKI DISEASE?

070

Jindal Ankur NEUROPSYCHIATRIC LUPUS WITH HEPATITIS IN A CHILD WITH CMV CO-INFECTION: IS CMV A SIMPLE BY-STANDER?

071

Johana Carmona Pérez

Liseth EFFECT OF MICROPARTICLES DERIVED FROM PATIENTS WITH LUPUS ERYTHEMATOSUS SYSTEMIC (SLE) ON MODULATION OF microRNAs 146a and 126, IN A MONOCYTE CELL LINE

053

Johnson Geoff SAFETY, EFFICACY AND TRANSCRIPTIONAL CHANGES FOLLOWING REPEATED ADMINISTRATION OF DAPIROLIZUMAB PEGOL IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM A PHASE I STUDY

034

Kalim Handono POTENTIAL NOVEL NATURAL B CELL DEPLETING AND IMMUNOSUPPRESSION AGENT IN LUPUS TREAPMENT USING BRYOPHYLLUM PINNATUM.IN SILICO AND IN PRISTANE INDUCED LUPUS MICE

035

Kalim Handono EFFECT OF CURCUMIN AND VITAMIN D ON DISEASE ACTIVITY, FATIGUE, AND CYTOKINE PROFILE IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH DEFICIENCY VITAMIN D

036

Kalim Handono IMMUNE MODULATION EFFECTS OF CURCUMIN IN PRISTANE INDUCED LUPUS MICE

037

Kalim Handono DEVELOPMENT OF THERAPY USING BRYOPHYLLUM PINNATUM TO DECREASE MATURATION AND INCREASE APOPTOTIC B CELLS FROM BALB/C LUPUS MICE: IN SILICO AND IN VITRO STUDY APPROACH

038

Katagiri Takaharu A CASE OF DERMATOMYOSITIS WITH ELEVATED SERUM KL-6 LEVEL ASSOCIATED WITH OVARIAN CANCER

PS-03*

Kato Yuko AUTOANTIBODIES IN SLE WITH PULMONARY HYPERTENSION PROMOTE A MIGRATION OF PULMONARY ARTERY SMOOTH MUSCLE CELLS

094

Khor Chiew Gek ACUTE PANCREATITIS AS AN INITIAL MANIFESTATION OF SYSTEMIC LUPUS ERYTHEMATOSUS : TWO CASE REPORTS

135

Khosravi-Hafshejani

Touraj PRIOR SUN EXPOSURE AND SKIN-SPECIFIC AUTO-ANTIBODIES ARE ASSOCIATED WITH SKIN DISEASE IN SYSTEMIC LUPUS ERYTHEMATOSUS

136

Kim Juyang ABSENCE OF HOST CD137 SIGNALING CONVERTS CHRONIC GVHD TOWARD ACUTE GVHD

006

Kim Woo Jin DYSBIOSIS AND GUT BARRIER DYSFUNCTION IN ANTIPHOSPHOLIPID SYNDROME AS REVEALED BY IGA-SEQ PROFILING

018

Kim Ji-Min IMPLICATIONS OF AUTOPHAGY FOR FUNCTINAL CHANGES OF RHEUMATOID ARTHRITIS FIBROBLAST-LIKE SYNOVIOCYTES

022

Kim Hae-Rim N-ACETYL-L-CYSTEINE (NAC) CONTROLS OSTEOCLASTOGENESIS THROUGH REGULATING TH17 DIFFERENTIATION AND RANKL PRODUCTION IN RHEUMATOID ARTHRITIS

054

Kim Kwangnam A CASE OF CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME WAS CONTROLLED WITH RITUXIMAB

072

Koilubaeva Gulazyk THE CLINICAL AND LABORATORY FEATURES OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN KYRGYZSTAN

095

Kuo Chang-Fu COMORBIDITIES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS PRIOR TO AND FOLLOWING DIAGNOSIS: CASE-CONTROL STUDY

096

Kurniati Nia CALCIUM AND VITAMIN D STATUS IN LUPUS CHILDREN IN JAKARTA, INDONESIA

073

Kurniawan Andree RISK FACTORS ASSOCIATED WITH THE OCCURRENCE OF AUTOIMMUNE HEMOLYTIC ANEMIA IN SYSTEMIC LUPUS ERYTHEMATOSUS

137

Lateef Aisha QUNANTITATIVE AND FUNCTIONAL EVALUATION OF PLASMA MICROPARTICLES IN SYSTEMIC LUPUS ERYTHEMATOSUS

055

Lee Eun-Ju URINARY BIOMARKER RELATED WITH TUBULAR INFLAMMATION IN LUPUS NEPHRITIS

039

Lee Jisoo PREVALENCE AND RISK FACTORS ASSOCIATED WITH NEUTROPENIA IN KOREAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOUS

081

Li Ting THE PHARMACOTHERAPEUTIC PATTERN OF LUPUS NEPHRITIS PATIENTS AND ITS EFFECT ON THE HOSPITALIZATION COST IN CHINA

097

Li Tzu-Hao ELDERLY SLE PATIENTS WITH PREVIOUS SKIN HERPES INFECTION AND HIGHER DOSE OF STEROID ENHANCED THE RISK OF SEVERE HERPES SIMPLEX INFECTION: A NATIONWIDE STUDY

098

Lim Ee Xin DELETION OF TACI PROTECTS AGAINST AUTOIMMUNE DISEASE IN LUPUS-PRONE MOUSE MODELS WITH DIFFERENT DISEASE MECHANISMS

040

Lizola Rene THE RELEVANCE OF VASCULAR EVALUATION IN SYSTEMIC LUPUS ERYTHEMATOSUS. RESULTS FROM AN INCEPTION COHORT

099

Ma Chi TERIFLUNOMIDE SODIUM CAN EFFECTIVELY CONTROL PROGRESS OF SPONTANEOUS LUPUS OF MRL/LPR MOUSE

041

Marpaung Blondina RELATIONSHIP BETWEEN INCREASED LEVELS OF ANTI-dsDNA WITH CLINICAL SYMPTOMS IN PATIENTS WITH SLE

139

Matsumoto Mitsuru EXPRESSION OF Ly6C/6G DEFINES A NOVEL AIRE-DEPENDENT SUBSET OF MEDULLARY THYMIC EPITHELIAL CELLS WITH TOLEROGENIC FUNCTION

007

Mazur-Nicorici Lucia ASSESSMENT OF THE RISK OF FLARES IN SYSTEMIC LUPUS ERITHEMATOSUS

102

McMahon Maureen BIOMARKERS OF ATHEROSCLEROSIS IN SLE IMPROVE AFTER TREATMENT WITH MYCOPHENOLATE MOFETIL

103

McMahon Maureen PLASMA MYELOPEROXIDASE IS INVERSELY ASSOCIATED WITH FUTURE ATHEROSCLEROSIS PROGRESSION AND INFLAMMATORY HDL FUNCTION IN SLE

104

Merayo-Chalico Javier EPIDEMIOLOGIC PROFILE OF ERECTILE DYSFUNCTION IN SLE: A MULTI-CENTER STUDY IN LATIN AMERICAN PATIENTS

105

Meroni Marianna SELECTED NAILFOLD CAPILLAROSCOPY PARAMETERS ARE PREDICTIVE OF SLE ONSET IN CONNECTIVE TISSUE DISEASES SUBGROUP

140

Minodora Mazur ASSESSMENT OF THE RISK OF FLARES IN SYSTEMIC LUPUS ERYTHEMATOSUS

141

Mizushina Kennosuke ACUTE MYOSITIS AS A FLARE MANIFESTATION OF SYSTEMIC LUPUS ERYTHEMATOSUS

106

Mohd Noh Malehah SERUM 25-HYDROXYVITAMIN D3 LEVELS AND CLINICAL COURSE OF SYSTEMIC LUPUS ERYTHEMATOSUS : A CROSS SECTIONAL RETROSPECTIVE COHORT STUDY IN A REFERRAL CENTRE

142

Mok Chi-Chiu EFFECT OF THE METABOLIC SYNDROME ON ORGAN DAMAGE AND MORTALITY IN CHINESE PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A LONGITUDINAL ANALYSIS

107

Molina Ramon Miguel CHARACTERISTICS AND RISK FACTORS FOR TUBERCULOSIS INFECTION AMONG FILIPINO PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

108

Molina Ramon Miguel PROTEIN-LOSING ENTEROPATHY AND FULMINANT INTESTINAL VASCULITIS IN A FILIPINO LUPUS PATIENT: A CASE REPORT

143

Molina Ramon Miguel GASTROINTESTINAL FLARES AMONG FILIPINO PATIENTS WITH SLE: A CASE SERIES

144

Monaghan Katherine DEPLETION OF PLASMACYTOID DENDRITIC CELLS WITH JNJ-56022473 MINIMISES INDUCTION OF AN INTERFERON GENE SIGNATURE IN RESPONSE TO TLR9 AND SLE IMMUNE COMPLEX STIMULATION

042

Muhammed Hafis PREVALENCE OF NPSLE IN NORTH-INDIAN SLE PATIENTS AND ITS IMPACT ON QUALITY OF LIFE

145

Musdalita Eva MASSIVE PAINLESS ASCITES A RARE FORM OF ONSET OF SYSTEMIC LUPUS ERYTHEMATOSUS : A CASE REPORT

146

Na Luo APOPTOSIS：INITIATION AND PROPAGATION IN THE KINETIC PROCESS OF SYSTEMIC LUPS ERYTHEMATOSUS

056

Nakayamada Shingo THE PATHOGENIC RELEVANCE OF T FOLLICULAR HELPER CELLS-PLASMABLASTS AXIS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

008

Nasir Noreen MYCOPHENOLATE MOFETIL FOR INDUCTION OF REMISSION IN LUPUS ENTERITIS

147

Nataraja Champa GILZ REPRESENTS A CHECKPOINT LIMITING CYCLICAL EXACERBATION OF INFLAMMATION IN SLE BY TYPE I INTERFERON

043

Nugraha Ricardo Adrian VITAMIN D DEFICIENCY AS NOVEL RISK FACTOR OF ACCELERATED ATHEROSCLEROSIS CARDIOASCULAR DISEASES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

109

Ogawa Eisuke SYSTEMIC LUPUS ERYTHEMATOSUS PRESENTING AS OCULOMOTOR DISTURBANCE

148

Okada Masato EARLY SEQUENTIAL COMBINATION THERAPY WITH MIZORIBINE AND TACROLIMUS IN SIXTY THREE PATIENTS OF LUPUS NEPHRITIS IN A SINGLE CENTER IN JAPAN

149

Oke Vilija DEFINING SUBSETS IN SLE: THE INTERPLAY AMONG IFN-λ1, IFN-α and Th17 AXIS CYTOKINES

150

Olsen Nancy REPOSITORY CORTICOTROPIN INJECTION EXERTS DIRECT ACUTE EFFECTS ON HUMAN B CELL GENE EXPRESSION DISTINCT FROM THE ACTIONS OF GLUCOCORTICOIDS

009

Paramaiswari Ayu CASE REPORT: ELECTROLYTE ABNORMALITY CAUSED BY SUSPECTED ACQUIRED GITELMAN SYNDROME IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENT

111

Park Yong-Wook MUCOSAL-ASSOCIATED INVARIANT T CELL DEFICIENCY IN SYSTEMIC LUPUS ERYTHEMATOSUS IS RELATED TO TO AN INTRINSIC DEFECT IN THE CA2+/CALCINEURIN/NFAT1 SIGNALING PATHWAY.

057

Parodis Ioannis SMOKING AND PRE-EXISTING ORGAN DAMAGE REDUCE THE EFFICACY OF BELIMUMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS

044

Parodis Ioannis A MASS CYTOMETRY (CYTOF) APPROACH TO STUDY B CELL ALTERATIONS DURING BAFF BLOCKADE TREATMENT WITH BELIMUMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS

045

Petri Michelle IMPACT OF DISEASE ACTIVITY ON ORGAN DAMAGE RISK OVER TIME IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) —THE HOPKINS LUPUS COHORT

110

Rangkuti Deske Muhadi MASSIVE PERICARDIAL EFFUSION IN YOUNG FEMALE OF SYSTEMIC LUPUS ERYTHEMATOSUS

114

Rus Horea RESPONSE GENE TO COMPLEMENT-32 PROMOTES PLASMA CELL DIFFERENTIATION AND ENHANCES LUPUS-LIKE CHRONIC GRAFT VERSUS HOST DISEASE

010

Sakata Kei TOLL-LIKE RECEPTOR 7-, BUT NOT TOLL-LIKE RECEPTOR 9-, MEDIATED INTERFERON-Α PRODUCTION FROM PLASMACYTOID DENDRITIC CELLS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

046

Sandal Sapna SOLUBLE RECEPTOR ACTIVATOR OF NUCLEAR FACTOR Κ B LIGAND (S RANK-L) LEVELS IN PEDIATRIC ONSET SLE

074

Santos Vivian REASONS FOR HOSPITALIZATION AMONG FILIPINO PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

112

Sawhney Sujata CLINICAL PROFILE AND LONG TERM OUTCOME OF CHILDHOOD SYSTEMIC LUPUS ERYTHEMATOSUS

075

Serrano Morales Rosa Maria ANTIPHOSPHOLIPID SYNDROME LONG TERM FOLLOW UP: REAL LIFE EXPERIENCE OF A SINGLE CENTRE

019

Shimamura Sanae RasGRP4 EXPRESSION IN RHEUMATOID SYNOVIUM PLAYS A CRITICAL ROLE VIA Ras- MAPK PATHWAY

023

Sinha Rajiv RITUXIMAB IN SLE MEMBRABOUS NEPHROPATHY 076

Siripaitoon Boonjing RISK FACTORS FOR BACTEREMIA IN THAI PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

115

Sjöberg AnnaKajsa SYSTEMIC LUPUS ERYTHEMATOSUS AND NEUROMYELITIS OPTICA SPECTRUM DISORDERS

116

Subramani Priyanka A RETROSPECTIVE ANALYSIS ON SYSTEMIC LUPUS ERYTHEMATOSUS IN THE INDIGENOUS AND NON-INDIGENOUS POPULATION IN CENTRAL AUSTRALIA FOCUSSING ON TREATMENT AND OUTCOMES OF LUPUS NEPHRITIS

118

Suh Chang-Hee THE LIVER X RECEPTOR IS HIGHLY UPREGULATED IN MONOCYTE DERIVED MACROPHAGE AND POTENTIATES TLR-DRIVEN CYTOKINE RELEASE ACCORDING TO GENOTYPE OF -1830 T > C POLYMORPHISM

058

Suh Chang-Hee HIERARCHICAL CLUSTER ANALYSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS

151

Su-Jin Moon FACTORS INFLUENCING ON HEALTH-RELATED QUALITY OF LIFE IN FEMALE SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH FIBROMYALGIA

117

Sun Fangfang TTP SECONDARY TO SLE: RITUXIMAB IMPROVES OVERALL BUT NOT RENAL SURVIVAL

119

Suryajaya Bernard Santoso ANTI-NUCLEAR ANTIBODY PATTERN AND CLINICAL MANIFESTATION PRESENTATION IN SYSTEMIC LUPUS ERYTHEMATOSUS

152

Svenungsson Elisabet ISCHEMIC STROKE IN SYSTEMIC LUPUS ERYTHEMATOSUS, -DISTRIBUTION OF SUBTYPES AND A RISK GENOTYPE IN THE STAT4 GENE

153

Syarief Dian LUPUS EXERCISE AND PERSONAL MEDICATION RECORD ON MOBILE APPLICATION TO HELP IMPROVE THE QUALITY OF LIFE OF PEOPLE WITH LUPUS

PS-04*

Tanaka Yoshiya EFFECTS OF BELIMUMAB ON CORTICOSTEROID USE IN A PIVOTAL PHASE III, RANDOMISED, PLACEBO CONTROLLED STUDY IN SUBJECTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN NORTH EAST ASIA

047

Tang Wei TARGETING SAHH AS A POTENTIAL THERAPEUTIC STRATEGY FOR AUTOIMMUNE DISEASES

048

Taylor Kristen EFFECTS OF AN ORAL SELECTIVE SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR IN A MOUSE MODEL OF SLE

024

Ugarte Berzal Estefania MATRIX METALLOPROTEINASE-9/MMP-9/GELATINASE B IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

059

Ugarte-Gil Manuel PROTECTIVE EFFECT OF ANTIMALARIALS ON THE RISK OF DAMAGE ACCRUAL IN SYSTEMIC LUPUS ERYTHEMATOSUS

113

Vasdev Vivek DEMOGRAPHY, CLINICAL AND IMMUNOGICAL PROFILE OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS FROM A TERTIARY CARE CENTER IN INDIA

154

Venegas Elaine CORRELATION OF HISTOPATHOLOGY WITH CLINICAL PARAMETERS IN LUPUS NEPHRITIS AMONG FILIPINOS

155

Virachitth Siriphone SOME ANTI-CALDIOLIPIN-BETA2-GPI ANTIBODIES BRING THROMBOPHILIC DIATHESIS BY THE DUAL REACTIVITY TO DNA AND INTERNALIZATION TO LIVE CELLS ACCOMPANYING DNA

020

Wong Josalind A LIFE LIVED WITH LUPUS: AN INTEGRATIVE REVIEW OF THE LITERATURE

060

Wu Chao-Yi ROLE OF TUBULOINTERSTITIAL LESIONS IN PREDICTING RENAL OUTCOME AMONG PEDIATRIC ONSET LUPUS NEPHRITIS – A RETROSPECTIVE COHORT STUDY

077

Yan Qingran IGURATIMOD INHIBITS HUMAN B CELL TERMINAL DIFFERENTIATION IN VITRO AND MAY BENEFIT PATIENTS WITH REFRACTORY LUPUS NEPHRITIS

049

Yang Huang-Yu MICROMANAGING LUPUS NEPHRITIS: MIR17-92 MODULATES REGULATORY T CELL ACTIVITY BY TARGETING FOXP3 CO-REGULATORS

011

Yang Yingyun PAN-DYSAUTONOMIA IN SYSTEMIC LUPUS ERYTHEMATOUS: TWO CASES OF SUCCESSFUL TREATMENT AND A REVIEW OF LITERATURE

120

Yap Desmond Yat-Hin LONG-TERM DATA ON SIROLIMUS TREATMENT IN LUPUS NEPHRITIS PATIENTS

050

Yim Ada Lok Yan DENDRITIC CELLS DISPLAY ABERRANT TOLL-LIKE RECEPTOR 7/9 RESPONSES IN SYSTEMIC LUPUS ERYTHEMATOSUS

061

Yoshinari Hiroko SUCCESSFUL TREATMENT OF REFRACTORY LUPUS NEPHRITIS WITH SECUKINUMAB IN A PATIENT COMPLICATED WITH PSORIASIS VULGARIS.

051

Zamora Leonid ROLE OF SEROLOGY IN DIAGNOSIS OF EARLY SLE AMONG FILIPINOS

156

Zapata Carlos Andres PROCALCITONIN AND EOSINOPENIA AS POTENTIAL BIOMARKERS OF INFECTION IN CRITICALLY ILL PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

121

Zapata Carlos Andres THE ROLE OR NEUTROPHIL-LYMPHOCYTE RATIO (NLR), AND OTHER BIOMARKERS (C - REACTIVE PROTEIN CRP, COUNT OF MONOCITES AND LYMPHOCITES) DIFFERENTIATING LUPIC ACTIVITY (FLARE) FROM INFECTION.

122

Zhao Jiuliang LONG-TERM PROGNOSIS AND PREDICTING FACTORS OF CHINESE PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME

021

Zhao Jiuliang THE PIVOTAL ROLE OF INTENSIVE IMMUNOSUPPRESSIVE THERAPY IN THE MANAGEMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS ASSOCIATED WITH PULMONARY ARTERIAL HYPERTENSION

157

Zhao Jiuliang LONG-TERM PROGNOSIS AND PREDICTING FACTORS OF CHINESE PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A MULTI-CENTER COHORT STUDY FROM CSTAR REGISTRY

158

Zhong Wei A HIGHER FREQUENCIES OF T HELPER 22 CELLS IN PATIENTS WITH NEW ONSET ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS

012

Zhou Qiao ALTERED PROPORTION OF TFH17 SUBSETS IN BRONCHOLALVEOLAR LAVAGE FLUID OF PATIENTS WITH INTERSTITIAL LUNG DISEASE CAUSED BY SYSTEMIC LUPUS ERYTHEMATOSUS

013

Zhou Haibo MIR-127-3p AS A NOVEL REGULATOR OF TYPE I INTERFERON SIGNALING PATHWAY IN SLE

062

Zuo Jianping DEVELOPMENT OF ARTEMISININ ANALOG SM934 IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS

052

Tuesday, 28 March

Last name First name Poster title Board number

Alzate Maria COFFEE CONSUMPTION AND CLINICAL OUTCOMES IN COLOMBIAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

081

Bae Sang Cheol UPDATE ON SLE-HLA ASSOCIATION: CONTRIBUTION OF ALLELE-SPECIFIC EXPRESSION IN ADDITION TO AMINO ACID CHANGES IN HLA ALLELES

015

Bankole Adegbenga A COMPARATIVE ANALYSIS OF GUT MICROBIOTA BETWEEN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS AND NON-AUTOIMMUNE CONTROLS: A SINGLE CENTER COHORT EXPERIENCE

082

Bankole Adegbenga A COMPARATIVE STUDY OF VITAMIN D LEVELS IN AUTOIMMUNE AND NON-AUTOIMMUNE DISEASE

083

Bankole Adegbenga THE RELATIONSHIP BETWEEN SOCIOECONOMIC FACTORS AND IMMUNOSUPPRESSIVE USE IN SYSTEMIC LUPUS ERYTHEMATOSUS

118

Berthier Celine C PEARL: PATHWAY EXPLORATION AND ANALYSIS IN RENAL DISEASE IN THE ACCELERATING MEDICINE PARTNERSHIP (AMP) LUPUS NETWORK

016

Bo miao Ju THE EXPRESSION OF SIGLEC-10 IS ELEVATED ON B LYMPHOCYTES AND ASSOCIATED WITH DISEASE ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

017

Brilot Fabienne HUMAN AUTOANTIBODIES FROM CHILDREN WITH MOVEMENT AND PSYCHIATRIC DISORDERS TARGET THE EXTRACELLULAR N-TERMINUS OF DOPAMINE-2 RECEPTOR

018

Budde Petra NOVEL AUTOANTIBODIES AGAINST THE INTERFERON-RESPONSIVE MAJOR VAULT PROTEIN (MVP) IN SYSTEMIC LUPUS ERYTHMATOSUS

019

Bundell Chrisitne ANTINUCLEAR ANTIBODIES IN IU/ML PREDICTS dsDNA AND ENA ANTIBODIES

087

Chan Edward High Titer ANA with Anti-DFS70 ALONE IS NOT TO BE CONSIDERED A VALID CRITERION FOR LUPUS

001

Chan Madelynn SINGLE NUCLEOTIDE POLYMORPHISMS (SNPs) OF INTEGRIN-ALPHA-M (ITGAM) ARE ASSOCIATED WITH LUPUS NEPHRITIS (LN) IN AN ASIAN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) COHORT

020

Chen Xiaosan THE COMPARISON BETWEEN CHEMILUMINESCENT IMMUNOASSAY AND LINE IMMUNOASSAY FOR THE DETECTION OF ANTIBODIES SPECIFIC TO SLE DIAGNOSIS: A RANDOMIZED, INDEPENDENT MULTI-CENTER CLINICAL STUDY IN CHINA

088

Chen Yen Fu PERICARDIAL EFFUSION AND CARDIAC TAMPONADE IN SYSTEMIC LUPUS ERYTHEMATOSUS

146

Choi May ANA-NEGATIVE SLE: RE-EVALUATION IN AN INTERNATIONAL INCEPTION COHORT

119

Davidson Anne THE ROLE OF TLR8 IN LUPUS NEPHRITIS 071

Deng Guo-min THE ROLE OF NEUTROPHILS IN ORGAN TISSUE DAMAGE IN SLE 072

Dewi Sumartini CORRELATION BETWEEN THE LEVELS OF BIOMARKERS P1NP, BAFF and sCD40L SERUM WITH SKIN FIBROSIS BASED ON MODIFIED RODNAN’S SKIN SCORE IN SYSTEMIC SCLEROSIS

089

Domínguez Amaia HEALTH-RELATED QUALITY OF LIFE (HRQOL), EMOTIONALITY THE DAY-TO-DAY PROBLEM SOLVING AND COPING IN LUPUS PATIENTS

090

Doria Andrea LUPUS LOW DISEASE ACTIVITY STATE: PREVALENCE AND EFFECT ON DAMAGE ACCRUAL IN A MONOCENTRIC COHORT OF 293 SLE PATIENTS

170

Edar Mary Flor Joy HIGHEST FREQUENCY OF CLINIC VISITS AND HOSPITALIZATIONS IN SLE AMONG RHEUMATIC DISEASES: 8 YEAR CENSUS OF A TERTIARY RHEUMATOLOGY CENTER

120

Edar Mary Flor Joy DISEASE ACTIVITY PATTERNS AMONG FILIPINO PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A 3-YEAR OBSERVATIONAL STUDY

148

Elkon Keith TLR8 ACTIVATION IN NEUTROPHILS IMPAIRS IMMUNE COMPLEX PHAGOCYTOSIS THROUGH FURIN-DEPENDENT SHEDDING OF FCGRIIA

073

Fikry Achmad ANTI - TNF ALFA INDUCED LUPUS : A CASE REPORT 091

Fujieda Yuichiro CLINICAL SIGNIFICANCE OF ANTI-DNA/NR2 ANTIBODIES IN DE NOVO NPSLE AND POST-STEROID NPSLE

021

G Arvind STUDY OF FAMILIAL AGGREGATION OF AUTOIMMUNE DISEASES IN ASIAN INDIAN LUPUS PATIENTS(PROBANDS)

121

Gatto Mariele PREDICTORS OF RENAL REMISSION, RENAL INSUFFICIENCY AND DAMAGE IN LUPUS NEPHRITIS

122

Gladman Dafna PREDICTORS OF GOOD LONG-TERM RENAL OUTCOMES 157

Golder Vera CONSTRUCT VALIDITY ASSESSMENT OF THE LUPUS LOW DISEASE ACTIVITY STATE (LLDAS) – A CASE BASED VALIDITY STUDY

149

Gómez-Puerta Jose A URINARY TWEAK LEVELS AS BIOMARKER OF LUPUS NEPHRITIS IN COLOMBIAN SLE PATIENTS

022

Gómez-Puerta Jose A PREVALENCE OF Anti-DFS70 ANTIBODIES IN A COLOMBIAN COHORT: A CASE-CONTROL STUDY

023

Gottschalk Timothy CD11b REGULATES INFLAMMATION, AUTOIMMUNITY AND ASSOCIATED PATHOLOGY IN A MODEL OF SYSTEMIC LUPUS ERYTHEMATOSUS

074

Gupta Aman PROFILE OF HENOCH SCHONLEIN PURPURA (HSP) NEPHRITIS: 23 YEARS EXPERIENCE AT A TERTIARY CARE CENTRE IN NORTH INDIA

092

Hall Sue UNDERSTANDING DISEASE BURDEN, SEVERITY AND PROGRESSION IN PATIENTS WITH CUTANEOUS LUPUS ERYTHEMATOSUS IN A REAL-WORLD SETTING

027

Hall Susan Audrey TEMPORAL RELATIONSHIP OF CUTANEOUS LUPUS ERYTHEMATOSUS AND SYSTEMIC LUPUS ERYTHEMATOSUS: A LARGE, RETROSPECTIVE COHORT STUDY

123

Hamijoyo Laniyati COMPARISON QUALITY OF LIFE OF PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND SYSTEMIC SCLEROSIS

150

Hanly John CEREBROVASCULAR EVENTS IN SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM AN INTERNATIONAL, INCEPTION COHORT STUDY

151

Hasni Sarfaraz IDENTIFICATION OF MicroRNA PREDICTIVE OF TREATMENT RESPONSE IN LUPUS NEPHRITIS

024

He Jing LOW-DOSE IL-2 CIRCUMVENTED mTOR SIGNALING IN T CELLS IN THE TREATMENT OF SLE

025

Hirahara Shinya USEFULNESS OF SOLUBLE PD-1 IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

026

Hoi Alberta TEN YEARS OF THE MONASH LUPUS CLINIC AND ONWARDS – MODEL OF A MULTIDISCIPLINARY SPECIALIST CLINIC PROVIDING IMPROVED HEALTHCARE QUALITY AND OUTCOMES FOR SLE PATIENTS

152

Hoi Alberta THE HIGH DISEASE ACTIVITY STATE IS AN ADVERSE PROGNOSTIC INDICATOR IN SLE AND DEFINES A CLINICALLY DISTINCT POPULATION

154

Hosono Yuji SPLICING FACTOR PROLINE/GLUTAMINE-RICH (SFPQ) IS A NOVEL AUTOANTIGEN OF anti-MDA5 ANTIBODY-POSITIVE DERMATOMYOSITIS/CLINICALLY AMYOPATHIC DERMATOMYOSITIS

093

Huang Jing-Long THE CHANGE OF COMPLEMENT REGULATORY PROTEINS AND DISEASE ACTIVITY OF SYSTEMIC LUPUS ERYTHEROMATOSUS

028

Huang Xiangyang THE ROLE OF PI3k, mTOR IN THE EXPRESSION OF INTERFERON –ALPHA INDUCED PROTEIN IFIT4 IN LUPUS

029

Huang Xiangyang THE CLINICAL ANALYSIS OF THE CHARACTERISTICS OF LUPUS MESENTERIC VASCULITIS (LMV) COMPARED WITH LUPUS NEPHRITIS

030

Inanc Murat A SINGLE CENTER EXPERIENCE OF RITUXIMAB TREATMENT IN 79 PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

086

Islam Md. Nazrul TUBERCULAR INFECTION IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS-A REPORT FROM AN ENDEMIC COUNTRY

084

Iwata Shigeru THE EFFICACY OF ANTI-CD20 ANTIBODY RITUXIMAB FOR REFRACTORY PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

002

Jindal Ankur IMMUNE THROMBOCYTOPENIA ASSOCIATED WITH LOCALIZED SCLERODERMA- REPORT OF 4 PEDIATRIC CASES.

094

Karp David LIKELIHOOD OF PATIENTS WITH INCOMPLETE LUPUS TO ENTER A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF HYDROXYCHLOROQUINE

004

Karp David SLE RISK HAPLOTYPES ARE ASSOCIATED WITH DEVELOPMENT OF SEROLOGIC AUTOIMMUNITY IN HEALTHY INDIVIDUALS

031

Kasitanon Nuntana INCIDENCE OF LUPUS NEPHRITIS FLARES AFTER COMPLETE RESPONSE TO INDUCTION AND RECEIVING 18 MONTHS OF MAINTENANCE PHASE IN CLINICAL PRACTICE

124

Khoshkhui Maryam EVALUATION OF ATOPY AND EOSINOPHILIA IN PATIENTS WITH PSORIASIS

005

Kim Ji-Min A CASE OF HEMOPHATOCYTIC SYNDROME DEVELOPED IN A KOREAN FEMALE PATIENT WITH DERMATOMYOSITIS

095

Kim Dam ANTIPHOSPHOLIPID ANTIBODY POSITIVITY AND RELATED CLINICAL CHARACTERISTICS IN KOREAN LUPUS PATIENTS

144

Koilubaeva Gulazyk OUTCOMES OF PREGNANCY OF KYRGYZ SLE PATIENTS 112

Kolarov Zlatimir DYSREGULATION OF miRNAs EXPRESSION LEVELS AND DISEASE ACTIVITY IN SLE PATIENTS

059

Komura Kazuhiro NAILFOLD VASCULAR FINDINGS OF ANTI-MELANOMA DIFFERENTIATION-ASSOCIATED GENE 5 ANTIBODY-POSITIVE PATIENTS WITH DERMATOMYOSITIS

033

Kusumo Wibowo Suryo Anggoro PREGNANCY OUTCOME OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS IN CIPTO MANGUNKUSUMO NATIONAL REFERRAL HOSPITAL, JAKARTA, INDONESIA

113

Lanata Cristina IDENTIFYING EXPOSURES TO CHEMICALS IN PATIENTS WITH SLE - “ A NON-TARGETED EXPOSOME APROACH"

034

Lang Tali LINKING MACROPHAGE MIGRATION INHIBITORY FACTOR AND NLRP3 IN THE PATHOGENESIS OF IL-1 DEPENDENT INFLAMMATORY DISORDERS

075

Lee Shin-Seok RISK FACTORS FOR AND COMPONENTS OF METABOLIC SYNDROME: A STRUCTURAL EQUATION MODELING ANALYSIS OF THE QUALITY OF LIFE OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

035

Lee Young H0 CIRCULATING PROLACTIN LEVEL IN SYSTEMIC LUPUS ERYTHEMATOSUS AND ITS CORRELATION WITH DISEASE ACTIVITY: A META-ANALYSIS

036

Lee Sang-Heon THE USE OF HAND PERFUSION SCINTIGRAPHY TO ASSESS RAYNAUD’S PHENOMENON ASSOCIATED WITH HAND-ARM VIBRATION SYNDROME

096

Li Ting INVESTIGATION OF DATA CAPTURE TECHNOLOGY ON CLINICAL PHENOTYPE DISTRIBUTION OF 4150 PATIENTS WITH SLE

037

Li Tzu-Hao USING DECISION TREE TO IDENTIFY THE ITP WITH HIGH PROBABILITY OF SLE DEVELOPMENT FROM A NATIONWIDE COHORT STUDY

125

Louthrenoo Worawit CLINICAL FEATURES, OUTCOMES AND RISK FACTORS FOR THE DEVELOPMENT OF POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES) IN THAI PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

097

Louthrenoo Worawit PERFORMACE OF SPECIFIC (SLE-QOL) AND GENERIC (SF-36) HEALTH RELATED QUALITY OF LIFE QUESTIONNAIRES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS – A LONGITUDINAL STUDY

155

Luu Queenie PROMOTES [PATIENT AND PHYSICIAN REPORTED OUTCOMES – MEASURES OF THE TRUE EXPERIENCE IN SLE]

156

Mackay Fabienne DELETION OF THE BAFF RECEPTOR TACI FULLY PROTECTS AGAINST SLE WITHOUT REDUCTION OF B CELL NUMBERS AND FUNCTION.

076

Macri Christophe THE CONTRIBUTION OF INTERFERON LAMBDA TO SLE 077

Manjarrez Orduno

Nataly HIGH FREQUENCY OF CIRCULATING TERMINALLY DIFFERENTIATED CD8+ T CELLS CHARACTERIZE SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH RENAL INVOLVEMENT

038

Marinho António EFFECT OF HIGH DOSE CHOLECALCIFEROL DURING SLE FLARES IN miR-146a EXPRESSION, REGULATORY T-CELLS AND IL-17A EXPRESSION.

039

Marinho António RELATION OF VITAMIN D LEVELS IN SLE NUMBER OF SEVERE FLARES

158

Masri Muchtar Raveinal POLYMORPHISM PROMOTOR GENE OF IL-4 AND IL-4 LEVEL AT GRAVES DISEASE PATIENTS

040

Meroni Marianna SAFETY AND EFFICACY OF MODIFIED-RELEASE PREDNISONE IN SYSTEMIC LUPUS ERYTHEMATOUS PREGNANCIES: AN IMPLEMENTED COHORT

114

Migliore Frank IMPROVING THE QUALITY OF CARE IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) THROUGH TIME-STRUCTURED, INFORMATION TECHNOLOGY-ENHANCED, QUALITY IMPROVEMENT INDICATOR-DRIVEN PATIENT MANAGEMENT.

159

Mirfeizi Zahra CORRELATION BETWEEN SIX MINUTE WALK TEST AND PLASMA PROBNP LEVEL WITH ECHOCARDIOGRAPHIC FINDINGS OF PULMONARY HYPERTENSION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOUS

041

Mohamed Said Mohd Shahrir CASE SERIES INVOLVING OBSTETRICS EXPERIENCES AND OUTCOMES IN CONNECTIVE TISSUE DISEASE PATIENT IN UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTRE (UKMMC): A SINGLE CENTRE EXPERIENCE

042

Mohamed Said Mohd Shahrir HYPERPROLACTINAEMIA ASSOCIATION WITH LUPUS NEPHRITIS DISEASE ACTIVITY

043

Mohammed Medhat Ali

Basma CLINICAL CHARACTERISTICS OF SYSTEMIC LUPUS ERYTHREMATOSUS IN AN EGYPTIAN POPULATION: A DESCRIPTIVE RETROSPECTIVE CASE SERIES

127

Mok Chi-Chiu EFFECT OF DISEASE REMISSION ON ORGAN DAMAGE AND QUALITY OF LIFE IN CHINESE PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

160

Mok Chi-Chiu SERUM 25-HYDROXYVITAMIN D3 LEVELS AND FLARES OF SYSTEMIC LUPUS ERYTHEMATOSUS: A LONGITUDINAL COHORT ANALYSIS

161

Monaghan Katherine IDENTIFICATION OF PLASMACYTOID DENDRITIC CELL INDUCED PROTEINS AS POTENTIAL BIOMARKERS FOR JNJ-56022473

044

Moon Kiwon THE PREVALENCE OF SYSTEMIC LUPUS ERYTHEMATOSUS HAS INCREASED IN SOUTH KOREA

128

Moriyama Rina CLINICAL USEFULNESS OF QUANTITATIVE MEASUREMENT OF ANTI-M-TYPE PHOSPHOLIPASE A2 RECEPTOR ANTIBODIES IN PATIENTS WITH MEMBRANOUS NEPHROPATHY AND COMPARISONS OF THREE QUANTITATIVE METHODS

032

Mukai Masaya PREGNANCY ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN OUR HOSPITAL.

115

Nagaraju Shankar Prasad ANA NEGATIVE RENAL LIMITED LUPUS NEPHRITIS –A RARE ENTITY

098

Nesbit Stephanie PREDICTORS OF EARLY RESPONSE TO RITUXIMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): RESULTS FROM THE BRITISH ISLES LUPUS ASSESSMENT GROUP BIOLOGICS REGISTER (BILAG-BR)

045

Nishiyama Susumu INCREASED CYSTATIN C/CREATININE RATIO REFLECTS HIGH DISEASE ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

162

Nossent Johannes EVIDENCE FOR A PRO-INFLAMMATORY AS WELL AS PROTECTIVE ROLE FOR IL-17A IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

046

Nossent Johannes LUPUS NEPHRITIS IN INDIGENOUS AUSTRALIANS: INCIDENCE, HISTOLOGY AND OUTCOME.

129

Odhiambo Jackline AN EVALUATION OF QUALITY OF LIFE IN AMBULATORY PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS ATTENDING RHEUMATOLOGY CLINIC IN KENYATTA NATIONAL HOSPITAL

163

Ogura Takehisa COMPARISON OF ULTRASONOGRAPHIC JOINT AND TENDON INVOLVEMENTS IN HANDS BETWEEN EARLY, TREATMENT-NAÏVE PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS

099

Olteanu Rodica CUTANEOUS LUPUS ERYTHEMATOSUS -EVALUATION OF LABORATORY INVESTIGATIONS COSTS FOR HOSPITALIZED CASES IN BUCHAREST DERMATOLOGICAL CLINIC COMPARED TO RECOMMENDED CORE SET INVESTIGATIONS BY EUROPEAN GUIDELINES

100

Ooi James DISCORDANCE OF PATIENT AND PHYSICIAN HEALTH STATUS CONCERNS IN SYSTEMIC LUPUS ERYTHEMATOSUS

164

Oon Shereen SERUM CYTOKINE ANALYSIS AND TRANSCRIPTIONAL BLOOD PROFILING REVEAL AN ASSOCIATION BETWEEN IL-3 AND IFN IN HUMAN SLE

047

Padiyar Shivraj URINARY VCAM 1 AS A DISEASE ACTIVITY INDICATOR IN LUPUS NEPHRITIS

048

Paras Bryan PREDICTORS OF END-STAGE RENAL DISEASE IN FILIPINOS WITH LUPUS NEPHRITIS: A CASE-CONTROL STUDY

130

Pawlak-Bus Katarzyna CLINICAL AND IMMUNOLOGICAL REMISSION IN POLISH COHORT OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

101

Pawlak-Bus Katarzyna CLINICAL AND IMMUNOLOGICAL ACTIVITY IN POLISH COHORT OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS TREATED WITH GLUCOCORTICOIDS

102

Perez-Alvarez Alberto THE ASSOCIATION BETWEEN WORLD DEVELOPMENT INDICATORS PER COUNTRY AND GENDER RATIO IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A BIG DATA APPROACH ANALYSIS

131

Perez-Alvarez Alberto BIG DATA IN SYSTEMIC LUPUS ERYTHEMATOSUS: PHENOTYPIC DISEASE EXPRESSION OF 171,000 ADULT PATIENTS

132

Perez-Alvarez Alberto WORLDWIDE PICTURE OF RENAL INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS USING A BIG DATA ANALYTICAL APPROACH

133

Petersen Martine Prütz FIRST REPORT OF INTRAUTERINE PERICARDIOCENTESIS IN A FETUS WITH NEONATAL LUPUS ERYTHEMATOSUS

116

Petri Michelle VITAMIN D DEFICIENCY IS ASSOCIATED WITH INCEASED SERUM CHOLESTEROL AMONG PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

165

Pettersson Susanne A COMPARISON OF PATIENTS’ AND PHYSICIANS’ ASSESSMENTS OF DISEASE ACTIVITY USING THE SWEDISH VERSION OF THE SYSTEMIC LUPUS ACTIVITY QUESTIONNAIRE

103

Pettersson Susanne COMPARISONS OF FATIGUE, ANXIETY AND DEPRESSION IN SYSTEMIC LUPUS ERYTHEMATOSUS, SYSTEMIC SCLEROSIS AND ANTI-NEUTROPHIL CYTOPLASMATIC ANTIBODY-ASSOCIATED VASCULITIS

104

Peycheva Veneta LABORATORY FINDINGS OF SYNOVIAL FLUID IN CONNECTIVE TISSUE DISEASES

105

Pisitkun Prapaporn TMEM173/STING IS CRUCIAL FOR LUPUS DEVELOPMENT IN Fcgr2b-DEFICIENCY MICE

078

Potturi Pragna A COMPARISON OF OVARIAN RESERVE IN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS FOLLOWING TREATMENT WITH INTRAVENOUS CYCLOPHOSPHAMIDE V/S ORAL MYCOPHENOLATE MOFETIL

007

Prabir Das Prabir ASSOCIATION OF C4A AND C4B GENOMIC COPY NUMBER VARIATIONS IN ADULT AND PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS

049

Qian Jie THE PATHOGENIC MECHANISMS OF SYSTEMIC LUPUS ERYTHEMATOSUS ASSOCIATED GENES PNP, PLEKHF2 AND ANKRD44

051

Rahmawati Lita INTERLEUKIN-17 (IL-17) SERUM AND CORRELATION WITH DISEASE ACTIVITY IN NEPHRITIS AND NON LUPUS NEPHRITIS

166

Ramamoorthy Ramesh CORRELATION OF URINARY BIOMARKERS MCP1 AND NGAL WITH LUPUS NEPHRITIS(LN) HISTOLOGY AND DISEASE ACTIVITY SCORE

052

Ramsey-Goldman Rosalind ALGORITHMS TO IDENTIFY SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) FROM ELECTRONIC HEALTH RECORD (EHR) DATA

167

Ranjana Walker Minz

Ranjana UNIQUE ASSOCIATION OF HLA-DRB1*15, HLA DRB1*03 AND EBV WITH ADULT AND PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS IN NORTH INDIA

050

Raymond Warren PRINCIPAL COMPONENT ANALYSIS AS A METHOD TO UNRAVEL THE RELATION BETWEEN DISEASE ACTIVITY AND CYTOKINE PROFILING IN SYSTEMIC LUPUS ERYTHEMATOSUS

134

Raymond Warren HOSPITALISATION FOR SYSTEMIC LUPUS ERYTHEMATOSUS IN WESTERN AUSTRALIA DOUBLES THE ALL-CAUSE MORTALITY RISK COMPARED TO CONTROLS, ESPECIALLY FOR MEDICARE RELIANT AND MALE PATIENTS

135

Raymond Warren HOSPITALISATION FOR COMORBID CONDITIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IS MORE FREQUENTLY DUE TO CARDIOVASCULAR AND RENAL COMPLICATIONS, SUBSEQUENTLY INCREASING THE RISK OF DEATH

136

Reynolds Mathew ASSESSING THE QUALITY, RELIABILITY AND READABILITY OF ONLINE HEALTH INFORMATION REGARDING SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

137

Ruifang Wu STUDY ON THE ROLE AND MECHANISMS OF ABERRANT EXPRESSION OF TRANSCRIPTION FACTOR WT1 IN THE PSORIASIS VULGARIS LESION FORMATION

053

Santos Vivian FAMILIALITY AND CONCORDANCE OF PRESENTING MANIFESTATIONS AMONG FILIPINO PATIENTS FROM LUPUS MULTIPLEX FAMILIES

054

Scofield Hal VERY RARE X CHROMOSOME ANEUPLOIDIES IN LUPUS AND SJOGREN'S

055

Seger Schristina GOING DOWN A DIFFERENT PATH”: A QUALITATIVE EXPLORATION OF COSTS INCURRED BY CANADIAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

147

Selvaraja Malarvili ROLE OF CYTOKINE IL-5 AND IL-25 AS BIOMARKERS IN SYSTEMIC LUPUS ERYTHEMATOSUS

056

Senturk Taskin THE RELATIONSHIP BETWEEN IL-10, IL-17, IL-23 AND VITAMIN D LEVELS, AND DISEASE ACTIVITY OF SYSTEMIC LUPUS ERYTHEMATOSUS

057

Senturk Taskin SULFASALAZINE-RELATED HYPERSENSITIVITY REACTIONS IN PATIENTS WITH RHEUMATIC DISEASES

171

Setiabudiawan Budi INDONESIAN EPIDEMIOLOGIC DATA OF PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS

139

Shimizu Takashi THE LEVEL OF CD64 EXPRESSION ON MONOCYTE CORRELATES WITH THE ACTIVITY OF LUPUS NEPHRITIS

058

Smith Kevin ANA AND ENA TESTING ALGORITHM: PERSPECTIVE OF A LARGE PUBLIC HOSPITAL LABORATORY IN NEW ZEALAND

106

Soh May Ching COULD PRETERM DELIVERY BE A SURROGATE MARKER FOR ACCELERATED DEVELOPMENT OF CARDIOVASCULAR EVENTS IN WOMEN WITH SLE?

140

Tan Justina Wei Lynn RAPIDLY PROGRESSIVE ILD IN IIM – THE SINGAPOREAN EXPERIENCE

060

Tan Ying PLASMA ADAMTS-13 ACTIVITY IN PROLIFERATIVE LUPUS NEPHRITIS: A LARGE COHORT STUDY FROM CHINA

107

Tan Cheryl Anne MATERNAL AND FETAL OUTCOMES AMONG FILIPINO PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A SINGLE CENTER STUDY

117

Tanaka Yoshiya DISEASE SEVERITY AND BURDEN IN JAPANESE PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS FROM CLAIMS DATABASE

126

Tangtanatakul Pattarin DOWN-REGULATION OF miR-10a INDUCES IL-8 IN HUMAN MESANGIAL CELLS STIMULATED WITH Anti-dsDNA IgG ANTIBODIES

061

Teh Lee-Suan USE OF A PATIENT-REPORTED OUTCOME MEASURE, THE LUPUSQOL TO REFER PATIENTS FOR FURTHER SUPPORT – A PRELIMINARY STUDY

153

Teh Lee-Suan FLARES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS 168

Thanadetsuntorn Chokchai COMPARISON OF CIRCULATING IMMUNE COMPLEX AND INTERLEUKIN-6 WITH STANDARD BIOMARKERS TO DETERMINE SLE DISEASE ACTIVITY

062

Tunnicliffe David INDUCTION AND MAINTENANCE TREATMENT OF PROLIFERATIVE LUPUS NEPHRITIS: AN UPDATED COCHRANE REVIEW.

008

Tunnicliffe David MULTI-SPECIALISTS’ PERSPECTIVES ON CLINICAL DECISION MAKING IN SYSTEMIC LUPUS ERYTHEMATOSUS: AN INTERVIEW STUDY

108

Ugarte-Gil Manuel PREDICTORS OF REMISSION AND LOW LUPUS DISEASE ACTIVITY STATUS (LLDAS): DATA FROM A MULTI-ETHNIC, MULTINATIONAL LATIN AMERICAN LUPUS COHORT

009

Undurti Das IS LUPUS AN INFLAMMATION RESOLUTION DEFICIENCY DISORDER?

063

Undurti Das ROLE OF BIOACTIVE LIPIDS IN AUTOIMMUNE DISEASES INCLUDING LUPUS

064

Vanya Magdi ASSESSING THE CONTENT VALIDITY OF THE SF-36, THE SKINDEX-29+3 PATIENT REPORTED OUTCOMES (PRO) INSTRUMENTS, AND PAIN, FATIGUE IN PATIENTS WITH CUTANEOUS LUPUS ERYTHEMATOSUS (CLE)

169

Venegas Elaine RENAL ACTIVITY AND DAMAGE INCUR HIGHEST MEDICAL COSTS AMONG FILIPINO PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

141

Wahono Cesarius Singgih THE EFFECT OF ADDING CURCUMIN ON VITAMIN D3 SUPPLEMENTATION ON THE DISEASE ACTIVITIES AND FATIQUE DEGREE, IN SLE PATIENTS WITH HYPOVITAMIN D

010

Wahono Cesarius Singgih THE EFFECT OF ADDING CURCUMIN ON VITAMIN D3 SUPPLEMENTATION ON ANTI-DSDNA LEVELS AND PROTEINURIA, IN SLE PATIENTS WITH HYPOVITAMIN D

011

Wahono Cesarius Singgih THE EFFECT OF ADDING CURCUMIN ON VITAMIN D3 SUPPLEMENTATION ON CYTOKINES BALANCE, IN SLE PATIENTS WITH HYPOVITAMIN D

012

Wahono Cesarius Singgih THE EFFECT OF VITAMIN D3 SUPPLEMENTATION ON THE ANTI-dsDNA LEVELS AND URINE PROTEIN IN SLE PATIENTS WITH HYPOVITAMIN D

013

Wahono Cesarius Singgih THE EFFECT OF VITAMIN D3 SUPPLEMENTATION ON THE DISEASE ACTIVITIES AND DEGREE OF FATIQUE IN SLE PATIENTS WITH HYPOVITAMIN D

014

Wang Guosheng IDENTIFICATION OF MAJOR CLINICAL CHARACTERISTICS OF CHINESE SLE PATIENTS AND LINEAR CORRELATIONS AMONG SLEDAI, SF-36 AND HADS-ANXIETY USING MOBLIE SMART SYSTEM OF DISEASE MANAGEMENT (SSDM)

003

Wang Jiehua ELEVATED IFIT3 IN MONOCYTES CONTRIBUTED TO HYPERACTIVE CGAS-STING SIGNALING PATHWAY IN SLE

065

Wang Jing Jing MASS SPECTROMETRIC SEQUENCING OF PRECIPITATING ANTI-RO REVEALS UNIQUE VH/VL PEPTIDE BIOMARKERS

066

Wang Ting TOLL-LIKE RECEPTOR 7 SIGNALING DRIVES TRANSITIONAL B CELLS EXPANSION AND AUTOANTIBODY PRODUCTION IN SYSTEMIC LUPUS ERYTHEMATOSUS

079

Widhani Alvina SEVERE PERIPHERAL ARTERY DISEASE IN PATIENT WITH SCLERODERMA MANAGED WITH ENDOVASCULAR TREATMENT: A CASE REPORT

109

Xiao Fei THE LONG-TERM OUTCOMES ON LEFLUNOMIDE TREATMENT IN PATIENTS WITH LUPUS NEPHRITIS: A TWELVE-YEAR FOLLOW-UP STUDY

006

xu liling A CROSS-SECTIONAL STUDY ON APPLICATION OF GLUCOCORTICOID IN SYSTEMIC LUPUS ERYTHEMATOUS PATIENTS IN CHINA

110

Yan Wang IN VIVO THERAPEUTIC SUCCESS OF MicroRNA-155 (miR-155) ANTAGOMIR IN A MOUSE MODEL OF LUPUS ALVEOLAR HEMORRHAGE

067

Yap Desmond Yat-Hin RELAPSE OF LUPUS NEPHRITIS – RISK FACTORS AND IMPACT OF MYCOPHENOLATE TREATMENT

142

Yap Desmond Yat-Hin PRE-EMPTIVE TREATMENT FOR ASYMPTOMATIC SEROLOGICAL REACTIVATION IN LUPUS NEPHRITIS PATIENTS – IMPACT ON CLINICAL FLARE RATE AND RENAL FUNCTION

143

Yeh Kuo-Wei SERUM IL-18 AS BIOMARKER IN PREDICTING LONG-TERM RENAL OUTCOME AMONG PEDIATRIC-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

068

Yim Ada Lok Yan AUTOIMMUNE-ASSOCIATED GENE CLEC16A REGULATES NLRP3 BUT NOT AIM2 INFLAMMASOME PATHWAY IN HUMAN MACROPHAGES

080

Yu Xiang MicroRNA-21 IS A CRITICAL REGULATOR OF AUTOIMMUNITY THROUGH PROMOTING EFFECTOR AND METABOLIC FUNCTION OF PATHOGENIC TH17 CELLS

069

Zamora Leonid RISK FACTORS FOR HERPES ZOSTER INFECTION AMONG FILIPINOS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A CASE CONTROL STUDY

145

Zamora-Medina Maricarmen ANTI-RNP/Sm ANTIBODIES PLUS LUPUS ANTICOAGULANT AS RISK FACTOR FOR THROMBOSIS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

138

Zapata Carlos Andres CHARACTERIZATION OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WHO WERE ADMITTED TO A UNIVERSITY HOSPITAL IN BOGOTA-COLOMBIA BETWEEN 2008 AND 2016

111

Zhang Ruijun INCREASED PERIPHERAL CD8 T CELL RESPONSES IN SLE BY LOW-DOSE IL-2 TREATMENT

085

Zhao Ming DEFECT OF BDH2 CONTRIBUTES TO DNA HYPOMETHYLATION IN CD4+ T CELLS OF SYSTEMIC LUPUS ERYTHEMATOSUS

070